Tuesday, May 29, 2007

Bradley Pharmaceuticals' CEO Makes Bid

Bradley Pharmaceuticals Inc.'s (BDY) chief executive Daniel Glassman offered approximately $350 million to take the company private. The stock price climbed $3.91 to close at $22.35.

0 Comments:

Post a Comment

<< Home